Used in the treatment of moderate to severe chronic plaque psoriasis, this reference antibody targets the CD6 receptor on T cells, modulating immune activation and reducing inflammation. It helps decrease the proliferation and migration of pathogenic T cells to the skin, leading to improved clinical symptoms and quality of life in psoriasis patients. Additionally, it has been explored for use in other autoimmune and inflammatory conditions due to its immunomodulatory effects.